Announcements Trials
Browse Landscape

Status

Available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 27Observational 1Expanded_access 1

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Sarcoma 1Primary Myelofibrosis 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Endometrial Neoplasms 1

Interventions

venetoclax 3fludarabine phosphate 3fludarabine 3navitoclax 2ibrutinib 2brexucabtagene autoleucel 2axicabtagene ciloleucel 2asparaginase erwinia chrysanthemi recombinant 2Cyclophosphamide 2zanubrutinib 1tisagenlecleucel 1tipifarnib 1tafasitamab 1sugemalimab 1selinexor 1plerixafor 1pirtobrutinib 1nilotinib 1midostaurin 1loncastuximab tesirine 1idelalisib 1glucarpidase 1eryaspase 1ceritinib 1Whole-Body Irradiation 1Tacrolimus 1Rituximab 1Proton Pump Inhibitors 1Mycophenolic Acid 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × selinexor × Lymphoid × Clear all
NCT07215832 2026-03-02

KEAP

Karyopharm Therapeutics Inc

Available
GynecologicLymphoidMyeloidPlasma cellSarcoma

Multiple Myeloma, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Endometrial Neoplasms, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡